Fennec Pharmaceuticals Stock Analysis

Fennec Stock Analysis Notes

About 13.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.26. Fennec Pharmaceuticals had not issued any dividends in recent years. The entity had 1:3 split on the 9th of September 2014. Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Fennec Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. To learn more about Fennec Pharmaceuticals call Rostislav Raykov at 919 636 4530 or check out https://fennecpharma.com.

Fennec Pharmaceuticals Investment Alerts

Fennec Largest EPS Surprises

View All Earnings Estimates

Fennec Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Fennec Stock Institutional Investors

Note, although Fennec Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Fennec Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 287.57 M.

Fennec Profitablity

The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.02) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.02.

Management Efficiency

Fennec Pharmaceuticals has return on total asset (ROA) of (0.0539) % which means that it has lost $0.0539 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.0559) %, meaning that it created substantial loss on money invested by shareholders. Fennec Pharmaceuticals' management efficiency ratios could be used to measure how well Fennec Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At present, Fennec Pharmaceuticals' Return On Equity is projected to increase significantly based on the last few years of reporting. At present, Fennec Pharmaceuticals' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 53.3 M, whereas Net Tangible Assets are projected to grow to (2.8 M).

Technical Drivers

As of the 17th of February 2026, Fennec Pharmaceuticals shows the Mean Deviation of 2.11, downside deviation of 2.84, and Coefficient Of Variation of 1612.8. Fennec Pharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Fennec Pharmaceuticals Price Movement Analysis

Fennec Pharmaceuticals Insider Trading Activities

Fennec Pharmaceuticals Outstanding Bonds

Fennec Pharmaceuticals Predictive Daily Indicators

Fennec Pharmaceuticals Corporate Filings

Fennec Pharmaceuticals Forecast Models

Fennec Pharmaceuticals' time-series forecasting models are one of many Fennec Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fennec Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Fennec Pharmaceuticals Bond Ratings

Fennec Pharmaceuticals financial ratings play a critical role in determining how much Fennec Pharmaceuticals have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Fennec Pharmaceuticals' borrowing costs.

Fennec Pharmaceuticals Debt to Cash Allocation

Fennec Pharmaceuticals currently holds 19.34 M in liabilities with Debt to Equity (D/E) ratio of 0.58, which is about average as compared to similar companies. Fennec Pharmaceuticals has a current ratio of 5.02, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Fennec Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.

Fennec Pharmaceuticals Total Assets Over Time

Fennec Pharmaceuticals Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Fennec Pharmaceuticals uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Fennec Pharmaceuticals Debt Ratio

38.0

It looks as if about 62% of Fennec Pharmaceuticals' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Fennec Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Fennec Pharmaceuticals, which in turn will lower the firm's financial flexibility.

Fennec Pharmaceuticals Corporate Bonds Issued

Fennec Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Fennec Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fennec shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Fennec Pharmaceuticals. By using and applying Fennec Stock analysis, traders can create a robust methodology for identifying Fennec entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Fennec analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Fennec analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Fennec Pharmaceuticals stock analysis indicators help investors evaluate how Fennec Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Fennec Pharmaceuticals shares will generate the highest return on investment. By understating and applying Fennec Pharmaceuticals stock analysis, traders can identify Fennec Pharmaceuticals position entry and exit signals to maximize returns.

When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.